Rockwell Medical, Inc. (RMTI): Price and Financial Metrics

Rockwell Medical, Inc. (RMTI): $1.51

0.03 (+2.03%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

F

Add RMTI to Watchlist
Sign Up

RMTI Price/Volume Stats

Current price $1.51 52-week high $6.24
Prev. close $1.48 52-week low $1.16
Day low $1.45 Volume 210,590
Day high $1.57 Avg. volume 219,863
50-day MA $1.48 Dividend yield N/A
200-day MA $2.08 Market Cap 44.34M

RMTI Stock Price Chart Interactive Chart >


Rockwell Medical, Inc. (RMTI) Company Bio


Rockwell Medical is a biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis. The company was founded in 1995 and is based in Wixom, Michigan.


RMTI Latest News Stream


Event/Time News Detail
Loading, please wait...

RMTI Latest Social Stream


Loading social stream, please wait...

View Full RMTI Social Stream

Latest RMTI News From Around the Web

Below are the latest news stories about ROCKWELL MEDICAL INC that investors may wish to consider to help them evaluate RMTI as an investment opportunity.

Rockwell Medical, Inc. (NASDAQ:RMTI): Are Analysts Optimistic?

We feel now is a pretty good time to analyse Rockwell Medical, Inc.'s ( NASDAQ:RMTI ) business as it appears the...

Yahoo | November 17, 2023

Rockwell Medical, Inc. (NASDAQ:RMTI) Q3 2023 Earnings Call Transcript

Rockwell Medical, Inc. (NASDAQ:RMTI) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Good morning, and welcome to Rockwell Medical’s Third Quarter 2023 Results Conference Call and Webcast. Please note this event is being recorded. At this time, I would like to turn the conference call over to Heather Hunter, Senior Vice President, Chief Corporate […]

Yahoo | November 15, 2023

Q3 2023 Rockwell Medical Inc Earnings Call

Q3 2023 Rockwell Medical Inc Earnings Call

Yahoo | November 15, 2023

Rockwell Medical (RMTI) Reports Q3 Loss, Tops Revenue Estimates

Rockwell Medical (RMTI) delivered earnings and revenue surprises of 41.67% and 0.43%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | November 14, 2023

Rockwell Medical Announces Third Quarter 2023 Results

WIXOM, Mich., November 14, 2023--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced financial and operational results for the three months ended September 30, 2023.

Yahoo | November 14, 2023

Read More 'RMTI' Stories Here

RMTI Price Returns

1-mo 7.09%
3-mo 9.42%
6-mo -10.12%
1-year -28.44%
3-year -84.94%
5-year -97.11%
YTD -20.11%
2023 86.21%
2022 -77.49%
2021 -59.41%
2020 -58.61%
2019 7.96%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!